LINKERBOT RAISES $3B SERIES B+, EYES $6B NEXT
AI DESK■ 2 MIN READ
MON, MAY 4, 2026■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
Chinese robotics startup Linkerbot, which controls over 80% of the global dexterous robotic hands market, completed a Series B+ funding round at a $3 billion valuation. The company is targeting a $6 billion valuation for its next financing round.
Linkerbot has established dominant market position in an emerging sector critical to humanoid robot development. The company specializes in highly dexterous robotic hands—mechanical appendages designed to mimic human finger precision and manipulation capabilities.
The Series B+ funding reflects investor confidence in Linkerbot's technology and market expansion potential. With 80% global market share, the startup has effectively become the primary supplier for companies developing advanced humanoid robots.
The $3 billion valuation represents significant growth from earlier funding rounds. The company's goal to reach $6 billion in the next round suggests aggressive expansion plans, likely including increased manufacturing capacity, R&D investment, and international market penetration.
Dexterous robotic hands represent a key component in humanoid robotics development. As major tech companies and robotics firms race to commercialize humanoid robots for manufacturing, logistics, and service industries, demand for sophisticated manipulation capabilities has accelerated.
Linkerbot's market dominance positions it at a critical juncture in the robotics supply chain. Unlike consumer-facing robotics companies, Linkerbot operates in the critical components layer—a position that typically enables higher margins and more stable revenue streams.
The company faces competitive pressure from international players, including academic spinoffs and established industrial automation firms developing comparable technologies. However, its early market leadership and manufacturing expertise have created substantial barriers to entry.
China's robotics sector has become increasingly competitive, with government support driving innovation across humanoid robotics, industrial automation, and AI-integrated systems. Linkerbot's valuation trajectory reflects broader investor appetite for Chinese robotics technology.
The funding round timing aligns with accelerating humanoid robot deployments globally. Major companies including Tesla, Boston Dynamics, and Chinese competitors have announced commercialization timelines, creating sustained demand for components like advanced robotic hands.
Linkerbot's next funding round at a $6 billion valuation would represent a doubling of current value, consistent with rapid growth in emerging robotics segments.
■ SOURCES
► Techmeme■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
YESTERDAY— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
YESTERDAY— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
MAY 29— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
MAY 29— Industry Desk